Clinical Trial Update: Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections [Phase 1]

View source ↗

Summary

Phase 1 study evaluating tissue penetration of ceftolozane/tazobactam in diabetic patients with lower limb infections; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Lower Limb Infection

Drugs mentioned

• Ceftolozane/Tazobactam (ceftolozane/tazobactam)

Snippet

Sponsor: Hartford Hospital | Conditions: Diabetes, Wound Infection | Phase 1 | Status: COMPLETED | Results posted: 2019-01-15